C5 and fatty liver disease: Several lines of evidence have shown that C3 activation contributes to both liver steatosis and inflammatory response, however, C5-deficient AFLD mice still exhibit hepatosteatosis but reduced inflammatory response.4 These studies further support that Gly-tRF is involved in regulation of liver steatosis but not inflammatory response.